Curant Health

What Curant Health does

Curant Health is an independent, nationally accredited specialty pharmacy founded in 2000 (as HealthStat Rx, rebranded in 2014) and headquartered in Smyrna, Georgia, with additional operations in St. Petersburg, Florida and an on-site pharmacy at the University of Kansas School of Medicine-Wichita opened in July 2025. The company operates a specialty pharmacy platform anchored by a proprietary Medication Care Management® (MCM) clinical methodology that combines dedicated care coordinators, pharmacists, and 24/7 patient engagement with technology including the MedPlan® enhanced EMR, the V.I.T.AL.™ (Variable Intervention Treatment Algorithm) predictive analytics engine that ingests daily medical and pharmacy claims data, and the Curalytics® SONAR business intelligence dashboard. Curant serves four primary customer segments — health systems and providers (including FQHCs, ACOs, and academic medical centers), health plans (Medicare Advantage, Medicaid, commercial), pharmaceutical manufacturers (with a dedicated Curant Rare™ unit focused on rare and orphan disease), and employers — through direct enterprise sales relationships.

The company generates revenue across five streams: specialty pharmacy dispensing for complex and chronic disease medications (recurring); Medication Care Management services priced on per-member-per-month or outcomes-based contracts with health plans, providers, and employers (recurring); real-world evidence and real-world data solutions through Curant Rare for pharmaceutical partners (professional services); health plan member solutions and business intelligence via the PlanPlus™ division (recurring PMPM); and 340B contract pharmacy services and program management fees for covered entities (transaction). Pricing is not publicly disclosed; the model is B2B with PMPM and outcomes-based contracts for health-plan clients and custom pricing for pharmaceutical manufacturer partnerships. Validated outcome metrics include a 55% increase in medication adherence versus standard of care, a 43% decrease in medical spend impacting Total Cost of Care, a 37% reduction in hospital admissions for polychronic patients, an 80% improvement in Health Related Quality of Life, an 89.7% real-world Hepatitis C cure rate (SVR12) in co-infected patients, and an NPS of 96 versus a specialty pharmacy average of 78.6.

Curant Health holds a rare combination of accreditations — one of only 15 organizations with simultaneous ACHC, URAC Mail Order, URAC Specialty Pharmacy, and VIPPS credentials, plus NABP and HITRUST certification — and has been a five-time Inc. 5000 honoree (2014-2017) with the company reported at over $200M in revenue in the 2017 ranking context. The company is privately held with no disclosed parent or institutional investor, has 101-250 employees, and operates as a wholly organic-growth organization with no disclosed funding rounds or acquisitions. Three operating subsidiaries — Curant Specialty, Curant Rare, and PlanPlus — structure go-to-market across the provider, pharma, and health-plan segments, supported by named partnerships with Humana, Security Health Plan, Virginia Premier, IntraBio (AQNEURSA), Corcept Therapeutics (IWILFIN), Johns Hopkins, and Cencora.

Name

Curant Health

Legal name

Curant Health Georgia, LLC and Curant Health Florida, LLC

Website

https://curanthealth.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

101–250 employees

Short description

Curant Health is an independent, nationally accredited specialty pharmacy operating since 2000, providing specialty medication dispensing, Medication Care Management, and real-world evidence services to health plans, health systems, pharmaceutical manufacturers (notably rare-disease partners), and employers across the United States.

Ownership category

akta.pro rank

Product category

Specialty Pharmacy Services

NAICS

Pharmacies and Drug Retailers (456110)

SIC

Services-Health Services (8000)

akta.pro primary industry

Specialty Pharmacies (Complex/High-Cost Therapies) (HLAFALAC)

akta.pro secondary industries

Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG), Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops) (CRAOAHAK)

Keywords

• Specialty pharmacy services
• Medication management programs
• Rare disease pharmacy
• Health plan solutions
• Chronic care coordination

Headquarters

HQ city

Smyrna

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Specialty Pharmacy Dispensing: Curant Health operates as a nationally accredited specialty pharmacy dispensing specialty and rare disease medications. Revenue is generated through prescription fulfillment for complex and chronic disease patients, with services including medication dispensing, adherence packaging, and clinical support.
2. Medication Care Management Services: The company provides Medication Care Management programs to health plans, providers, and employers on a per-member-per-month or outcomes-based contract basis. Services include clinical care coordination, patient outreach, adherence monitoring, and care management, with pricing tied to measurable outcomes such as TCOC reduction and adherence improvement.
3. Real-World Evidence and Data Solutions: Curant Rare provides real-world evidence (RWE) and real-world data (RWD) solutions to pharmaceutical partners for rare disease therapies, supporting product reporting, adverse event monitoring, and commercialization support.
4. Health Plan Member Solutions (PlanPlus): PlanPlus division provides health plan member solutions including medication care management, business intelligence, and analytics services, generating revenue on a per-member-per-month basis with demonstrated ROI (e.g., 5:1 ROI for Security Health Plan).
5. 340B Contract Pharmacy Services: Curant Health offers 340B contract pharmacy services and medication management support programs to 340B covered entities, generating revenue through pharmacy fulfillment and program management fees.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

Core offering

Curant Health operates as an independent, nationally accredited specialty pharmacy that dispenses specialty and rare disease medications while delivering Medication Care Management (MCM) clinical programs to health plans, health systems, providers, and pharmaceutical manufacturers. Services include specialty drug fulfillment, adherence packaging, longitudinal patient engagement by dedicated pharmacists and care coordinators, predictive risk stratification via its proprietary V.I.T.AL. algorithm and MedPlan EMR, and real-world evidence generation for pharma partners. The company is structured into three business units: Curant Specialty (providers), Curant Rare (rare disease pharma), and PlanPlus (health plans).

Differentiator

Problem solved

Functional benefit

Brands

• Curant Specialty: Specialty pharmacy division serving health systems, university medical centers, FQHCs, specialty practices, and ACOs with complex and chronic disease management.
• Curant Rare
• PlanPlus
• CuraPak
• aURa
• PrEP & Prevention

Products and services

• Curant Specialty Pharmacy Services Specialty pharmacy dispensing and care management services for complex and chronic disease patients, delivered to provider organizations including health systems, FQHCs, specialty practices, and ACOs. Includes medication fulfillment, adherence packaging, 340B contract pharmacy support, and Medication Care Management.
• Curant Rare Disease Specialty Pharmacy Specialty pharmacy, patient support, and real-world evidence solutions dedicated to rare and orphan disease therapies for pharmaceutical manufacturer partners. Supports exclusive and limited distribution partnerships and bespoke patient journeys.
• PlanPlus Health Plan Member Solutions Medication Care Management, business intelligence, and analytics services for health plan members (Medicare Advantage, Medicaid, Commercial) focused on improving medication adherence, Star ratings, and reducing Total Cost of Care, priced on per-member-per-month or outcomes-based contracts.
• Medication Care Management (MCM) Proprietary clinical methodology combining validated, relationship-based longitudinal protocols with personalized care, including dedicated care coordinators, pharmacists, monthly patient contact, and 24/7 access to improve medication adherence and quality of life outcomes for complex and chronic disease patients.
• CuraPak Integrated Care and Pharmacy Fulfillment

Quantifiable outcome

• 55% increase in Medication Adherence vs. Standard of Care
• +11 more outcomes

Named customers12 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

Partnerships

17 partnerships are on record, tiered core and minor.

• CencoracoreStrategic or Co-development Partner · 22 January 2026Strategic collaboration between Curant Rare and Cencora (a global pharmaceutical solutions organization) to provide pharmaceutical companies developing rare disease therapies with an integrated commercialization solution. Leverages Cencora's pharmaceutical logistics services and commercialization solutions (pharmacovigilance, market access support) with Curant Rare's specialty pharmacy services and omnichannel patient engagement. Aims to streamline the path to commercialization, optimize patient journeys, and expedite speed-to-therapy for rare/orphan drugs.
• Corcept TherapeuticscoreStrategic or Co-development Partner · 18 August 2025Exclusive pharmacy partnership for IWILFIN, the first and only FDA-approved oral maintenance therapy shown to cut the risk of high-risk neuroblastoma relapse in half. Began August 2025.
• University of Kansas School of Medicine-Wichita Medical Practice AssociationcoreStrategic or Co-development Partner · 17 July 2025On-site pharmacy partnership at the University of Kansas School of Medicine-Wichita Medical Practice Association. Opened July 2025 to enhance patient convenience and deliver comprehensive care by combining doctor visits with pharmacy services.
• IntraBiocoreStrategic or Co-development Partner · 30 September 2024Exclusive specialty pharmacy partnership for AQNEURSA (levacetylleucine), the first FDA-approved stand-alone therapy for Niemann-Pick Disease Type C. Curant Health provides exclusive dispensing, patient support, and real-world evidence generation for this rare genetic disorder affecting approximately 1 in 100,000 live births.
• BioCareSD and LogiCare3PLcoreChannel Partner/ Reseller/ Distributor · 28 August 2023Partnership with BioCare Inc. companies' BioCareSD (leading distributor of life-saving therapies) and LogiCare3PL (3PL solution) to create an enhanced and simplified single-source ecosystem supporting complex rare disease patients and pharma partners. Combines distribution, fulfillment, and patient journey optimization.
• Security Health PlancoreStrategic or Co-development Partner · 28 March 2023Strategic partnership launched April 2023 between Security Health Plan of Wisconsin and Curant Health's PlanPlus division to achieve Total Cost of Care savings. PlanPlus provides Medication Care Management services to eligible SHP members with congestive heart failure and complex chronic conditions. Year 1 results: 5:1 ROI, $585.98 PMPM TCOC reduction, 39.5% hospital admission reduction, 15.6% ER visit reduction, 90.6% medication adherence achieved.
• HumanacoreStrategic or Co-development Partner · 8 September 2021Pilot program partnership between Curant Health and Humana launched September 2021 to address medication adherence and enhance patient care for Humana members suffering from Chronic Heart Failure (CHF) and Chronic Obstructive Pulmonary Disease (COPD).
• Collaborative Health Systems (WellCare)coreStrategic or Co-development Partner · 24 May 2017Pilot program launched May 2017 between Collaborative Health Systems (a WellCare company) and Curant Health to improve medication adherence and overall health outcomes for individuals with multiple chronic conditions (poly-chronic patients).
• Chattanooga CAREScoreStrategic or Co-development PartnerPartnership with Chattanooga C.A.R.E.S. (a 340B covered entity and Ryan White grantee) to offer highly coordinated clinical services, reporting, and analytics for HIV patients. Program achieved 90.5% medication adherence (measured by viral load), 69% increase in adherence, and 86% reduction in hospital readmissions. Partnership expanded in October 2016.
• VCU ID CliniccoreStrategic or Co-development PartnerPartnership with Virginia Commonwealth University Infectious Disease Clinic for proactive care coordination for Ryan White program patients. Curant Health fills gaps in care coordination for providers of all types including 340B covered entities and university hospitals.
• Cempa Community CarecoreStrategic or Co-development PartnerPartnership with Cempa Community Care (a 340B covered entity) where Curant's care management program helped achieve 90.5% adherence as measured by viral load for enrolled HIV patient population.
• Johns Hopkins MedicinecoreStrategic or Co-development PartnerMultiple clinical research partnerships including Project A.L.I.V.E. (24-month study examining IBD medication adherence and chronic care management), first-ever study measuring MTM impact on IBD patients, and ongoing collaboration with the Meyerhoff Inflammatory Bowel Disease Center. Johns Hopkins study found MTM increases adherence over 30% compared to standard of care.
• Northwestern University Feinberg School of MedicinecoreStrategic or Co-development PartnerCollaborative study evaluating the efficacy of prospective post-induction infliximab dosing based on trough level in patients with IBD. Study examines impact of trough level-based dosing on clinical and endoscopic remissions.
• Purdue UniversitycoreStrategic or Co-development PartnerResearch partnership with Purdue University and Amedisys demonstrating 86% readmission reduction in risk level one patients through medication therapy management. Study showed $2.7 billion net savings possible for Medicare through MTM.
• Louisiana Physicians ACO (LPACO)minorStrategic or Co-development PartnerACO partnership showing decrease in medical spend of $519.93 per member per month, with two-thirds of patients showing monthly decrease in medical spend averaging $950.27.
• Benchworks ConsultingminorImplementation/ SI/ Consulting PartnerPartnership with Benchworks Consulting (BW Consulting) to integrate management consulting services with best-in-class patient activation programs. Announced August 2021.
• rare360minorGTM or Marketing PartnerAccepted into rare360, a Rare Advocacy Movement program dedicated to strengthening, protecting and unifying community-based activists and community-focused allied stakeholders. Prestigious and exclusive program available only to thoroughly vetted organizations.

Scale indicators16 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Optum Specialty Pharmacy (UnitedHealth Group): Specialty pharmacy within Optum Rx, the PBM of UnitedHealth Group. A direct competitor across all of Curant's segments, with preferred-network steering and integrated medical/pharmacy economics.
• Walgreens Specialty Pharmacy: Specialty pharmacy of Walgreens Boots Alliance, named alongside Curant in ACHC/URAC/VIPPS accreditation context. Competes in dispensing, care management, and rare-disease support at national scale.
• CVS Specialty (CVS Health): Specialty pharmacy arm of CVS Health, the largest U.S. pharmacy and PBM operator. Competes across most of Curant's core categories with structural advantages from PBM integration and national retail footprint.

Direct peers

• BioPlus Specialty Pharmacy: Specialty pharmacy focused on complex chronic conditions including oncology, autoimmune, and HIV. Direct competitor in specialty dispensing with care management overlay, now part of CarelonRx (Elevance Health).
• PANTHERx Rare: Independent, URAC-accredited specialty pharmacy focused exclusively on rare and orphan diseases. Closest direct peer to Curant Rare: similar limited-distribution dispensing model, high-touch patient support, and exclusive manufacturer partnerships for ultra-rare therapies.
• US Bioservices (Cencora): Specialty pharmacy division of Cencora (formerly AmerisourceBergen) serving patients with chronic and complex conditions. Directly comparable in dispensing + adherence model, and the Cencora collaboration with Curant positions these firms simultaneously as partners and competitors.
• Diplomat Pharmacy (Optum Specialty Pharmacy): Independent specialty pharmacy acquired by Optum. Historically competed with Curant as an independent specialty pharmacy before being absorbed by a PBM-owned platform — illustrates the consolidation pressure Curant faces.
• Shields Health Solutions: Specialty pharmacy integrator embedded in health systems, providing onsite and integrated specialty pharmacy services for complex patient populations. Comparable in serving health systems and ACOs with chronic-disease patients via embedded pharmacy and adherence programs.
• Avella Specialty Pharmacy (Optum): Specialty pharmacy focused on complex disease categories including oncology, fertility, and hepatitis C. Now part of Optum; competes with Curant in dispensing + clinical management for specialty populations.

Emerging players

• AscellaHealth: Specialty pharmacy and care management organization serving complex patient populations with a focus on rare/specialty conditions and health plan partnerships. Comparable in pharmacy + care management model, with growing emphasis on rare disease distribution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/curanthealth
• Facebookfacebook.com/curanthealth
• LinkedInlinkedin.com/company/5001964
• Instagraminstagram.com/curanthealth
• Pinterestpinterest.com/curanthealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Curant Health